These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1309 related articles for article (PubMed ID: 32571934)

  • 41. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
    Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
    Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo.
    Rhodin MHJ; Reyes AC; Balakrishnan A; Bisht N; Kelly NM; Gibbons JS; Lloyd J; Vaine M; Cressey T; Crepeau M; Shen R; Manalo N; Castillo J; Levene RE; Leonard D; Zang T; Jiang L; Daniels K; Cox RM; Lieber CM; Wolf JD; Plemper RK; Leist SR; Scobey T; Baric RS; Wang G; Goodwin B; Or YS
    Nat Commun; 2024 Aug; 15(1):6503. PubMed ID: 39090095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity.
    Faizuloev E; Gracheva A; Korchevaya E; Smirnova D; Samoilikov R; Pankratov A; Trunova G; Khokhlova V; Ammour Y; Petrusha O; Poromov A; Leneva I; Svitich O; Zverev V
    Vaccine; 2023 Jan; 41(4):892-902. PubMed ID: 36528447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase.
    Cross RW; Agans KN; Prasad AN; Borisevich V; Woolsey C; Deer DJ; Dobias NS; Geisbert JB; Fenton KA; Geisbert TW
    Virol J; 2020 Aug; 17(1):125. PubMed ID: 32811514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
    Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.
    Ohno M; Sasaki M; Orba Y; Sekiya T; Masum MA; Ichii O; Sawamura T; Kakino A; Suzuki Y; Kida H; Sawa H; Shingai M
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Leist SR; Dinnon KH; Schäfer A; Tse LV; Okuda K; Hou YJ; West A; Edwards CE; Sanders W; Fritch EJ; Gully KL; Scobey T; Brown AJ; Sheahan TP; Moorman NJ; Boucher RC; Gralinski LE; Montgomery SA; Baric RS
    Cell; 2020 Nov; 183(4):1070-1085.e12. PubMed ID: 33031744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine.
    Xu J; Liu M; Niu X; Hanson J; Jung K; Ru P; Tu H; Jones DM; Vlasova AN; Saif LJ; Wang Q
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
    Shan C; Yao YF; Yang XL; Zhou YW; Gao G; Peng Y; Yang L; Hu X; Xiong J; Jiang RD; Zhang HJ; Gao XX; Peng C; Min J; Chen Y; Si HR; Wu J; Zhou P; Wang YY; Wei HP; Pang W; Hu ZF; Lv LB; Zheng YT; Shi ZL; Yuan ZM
    Cell Res; 2020 Aug; 30(8):670-677. PubMed ID: 32636454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
    Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY
    J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
    Sun J; Zhuang Z; Zheng J; Li K; Wong RL; Liu D; Huang J; He J; Zhu A; Zhao J; Li X; Xi Y; Chen R; Alshukairi AN; Chen Z; Zhang Z; Chen C; Huang X; Li F; Lai X; Chen D; Wen L; Zhuo J; Zhang Y; Wang Y; Huang S; Dai J; Shi Y; Zheng K; Leidinger MR; Chen J; Li Y; Zhong N; Meyerholz DK; McCray PB; Perlman S; Zhao J
    Cell; 2020 Aug; 182(3):734-743.e5. PubMed ID: 32643603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
    Zhou G; Zhao Q
    Int J Biol Sci; 2020; 16(10):1718-1723. PubMed ID: 32226289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
    Haagmans BL; Noack D; Okba NMA; Li W; Wang C; Bestebroer T; de Vries R; Herfst S; de Meulder D; Verveer E; van Run P; Lamers MM; Rijnders B; Rokx C; van Kuppeveld F; Grosveld F; Drabek D; Geurts van Kessel C; Koopmans M; Bosch BJ; Kuiken T; Rockx B
    J Infect Dis; 2021 Jun; 223(12):2020-2028. PubMed ID: 34043806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.